AK112 Combination Therapy as First Line Treatment for Metastatic Digestive System Neuroendocrine Cancer
Clinical trial NCT07712094 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07712094
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2029-02-27
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.